Despasmol en es it fr

Despasmol Brand names, Despasmol Analogs

Despasmol Brand Names Mixture

  • No information avaliable

Despasmol Chemical_Formula


Despasmol RX_link

No information avaliable

Despasmol fda sheet

Despasmol msds (material safety sheet)

Despasmol Synthesis Reference

No information avaliable

Despasmol Molecular Weight

309.469 g/mol

Despasmol Melting Point

< 25 oC

Despasmol H2O Solubility

Soluble as HCl salt

Despasmol State


Despasmol LogP


Despasmol Dosage Forms

Tablets (oral, 1 mg)

Despasmol Indication

Used for the symptomatic treatment of parkinsonism.

Despasmol Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Despasmol Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Despasmol side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Despasmol Patient Information

Despasmol Organisms Affected

Humans and other mammals